Anti-GPR52 monoclonal antibody

Pre-made anti-GPR52 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPR52/GPR52 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0940-Ab-1/ GM-Tg-hg-IP0940-Ab-2Anti-Human GPR52 monoclonal antibodyHuman
GM-Tg-rg-IP0940-Ab-1/ GM-Tg-rg-IP0940-Ab-2Anti-Rat GPR52 monoclonal antibodyRat
GM-Tg-mg-IP0940-Ab-1/ GM-Tg-mg-IP0940-Ab-2Anti-Mouse GPR52 monoclonal antibodyMouse
GM-Tg-cynog-IP0940-Ab-1/ GM-Tg-cynog-IP0940-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR52 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0940-Ab-1/ GM-Tg-felg-IP0940-Ab-2Anti-Feline GPR52 monoclonal antibodyFeline
GM-Tg-cang-IP0940-Ab-1/ GM-Tg-cang-IP0940-Ab-2Anti-Canine GPR52 monoclonal antibodyCanine
GM-Tg-bovg-IP0940-Ab-1/ GM-Tg-bovg-IP0940-Ab-2Anti-Bovine GPR52 monoclonal antibodyBovine
GM-Tg-equg-IP0940-Ab-1/ GM-Tg-equg-IP0940-Ab-2Anti-Equine GPR52 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0940-Ab-1/ GM-Tg-hg-IP0940-Ab-2; GM-Tg-rg-IP0940-Ab-1/ GM-Tg-rg-IP0940-Ab-2;
GM-Tg-mg-IP0940-Ab-1/ GM-Tg-mg-IP0940-Ab-2; GM-Tg-cynog-IP0940-Ab-1/ GM-Tg-cynog-IP0940-Ab-2;
GM-Tg-felg-IP0940-Ab-1/ GM-Tg-felg-IP0940-Ab-2; GM-Tg-cang-IP0940-Ab-1/ GM-Tg-cang-IP0940-Ab-2;
GM-Tg-bovg-IP0940-Ab-1/ GM-Tg-bovg-IP0940-Ab-2; GM-Tg-equg-IP0940-Ab-1/ GM-Tg-equg-IP0940-Ab-2
Products NameAnti-GPR52 monoclonal antibody
Formatmab
Target NameGPR52
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPR52 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0940-Ag-1Recombinant multi-species GPR52 protein


    Target information

    Target IDGM-IP0940
    Target NameGPR52
    Gene ID9293,620246,684623,708279,100683121,101095630,506159,100052614
    Gene Symbol and SynonymsEG620246,GPR52
    Uniprot AccessionQ9Y2T5,A6QLE7
    Uniprot Entry NameGPR52_HUMAN,GPR52_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000203737
    Target ClassificationGPCR

    The target: GPR52, gene name: GPR52, also named as . Members of the G protein-coupled receptor (GPR) family play important roles in signal transduction from the external environment to the inside of the cell.[supplied by OMIM, Jul 2002].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.